Ovarian Cancer: An Overview Of all gynecologic malignancies, ovarian cancer continues to have the highest mortality and is the most difficult to diagnose. In the United States female population, ovarian cancer ranks fifth in absolute mortality among cancer related deaths (13,000/yr). In most reported cases, ovarian cancer, when first diagnosed is in stages III or IV in about 60 to 70% of patients which further complicates treatment of the disease (Barber, 3). Early detection in ovarian cancer is …showed first 75 words of 4247 total…

…showed last 75 words of 4247 total…Al-Nafussi, A. (1995). Intracytoplasmic lumina and mucinous inclusions in ovarian carcinoma. Histopathology, 26, 181-184. Piver, S. (Ed.). (1987). Ovarian Malignancies. New York: Churchill Livingstone. Sharp, F., Mason, P., Blackett, T., & Berek, J. (1995). Ovarian Cancer 3. New York: Chapman & Hall Medical. Yamada, K., & Kiyoshi, O. (1995). Monoclonal antibody, Mab 12C3, is a sensitive immunohistochemical marker of early malignant change in epithelial ovarian tumors. Anatomic Pathology, 103, 288-294. Yoonessi, M., Weldon, D., & Sateesh, S. (1984). Clear cell ovarian carcinoma. Journal of Surgical Oncology, 27, 289-297.